Evidence map›Paper›PMID 34757532›Full record

ArticleRheumatology and therapy2022

Considering Immuno-autonomics in Stratifying Successful Treatment of Rheumatoid Arthritis with Tumor Necrosis Factor Inhibition: Comment on Cohen et al. Rheumatol Ther 2021 June 19.

Andrew J Holman, Edward Keystone, Ernest Choy, Daniel Furst, Peter Taylor, Norman Gaylis

Open access · goldAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Rheumatology and therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 85% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 3 countries.

Andrew J HolmanPacific Rheumatology Associates, Inc PS, Seattle, WA, USA. andrew.holman@inmedix.com.
Edward KeystoneDepartment of Medicine, Keystone Consulting Enterprises Inc, University of Toronto, Toronto, Canada.
Ernest ChoyDivision of Infection and Immunity, Arthritis Research UK CREATE Centre and Welsh Arthritis Research Network (WARN), Cardiff University School of Medicine, Cardiff, UK.
Daniel FurstUniversity of California in Los Angeles Academy, Los Angeles, CA, USA.
Peter TaylorBotnar Research Centre, University of Oxford, Oxford, UK.
Norman GaylisArthritis and Rheumatic Disease Specialties, Aventura, FL, USA.
Arthritis and Rheumatic Disease Specialties · USCardiff University · GBRheumatology Consultants · USUniversity of Oxford · GBUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Heart rate variabilityImmuno-autonomicsRheumatoid arthritisTumor necrosis factor inhibition

Identifiers

PMID34757532
PMCPMC8814136
OpenAlexW3205906452

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.